CAS RN: 937263-43-9
Irbinitinib
Product Availability
Choose a grade to view its available package options.
10 package records10 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260413 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260103 |
10g |
In stock |
Shanghai | Inquiry |
| Batchno.20251026 |
1g |
In stock |
Shanghai, Shenzhen | Inquiry |
| Batchno.20251129 |
250mg |
In stock |
Shanghai, Chengdu | Inquiry |
| Batchno.20251002 |
5g |
In stock |
Shanghai, Shenzhen | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250313 |
5mg / 25mg / 100mg |
Confirm by inquiry |
Shanghai | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260409 |
100mg |
In stock |
| Inquiry |
| Batchno.20251003 |
25mg |
In stock |
| Inquiry |
| Batchno.20250214 |
50mg |
In stock |
| Inquiry |
| Batchno.20250124 |
5mg |
In stock |
| Inquiry |
-
Product code:
starshine_CAS937263-43-9
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
937263-43-9 / 6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine
Standard CAS: 937263-43-9
Multi CAS: No
Basic Information
CAS
937263-43-9
Multi CAS
No
Molecular Formula
C26H24N8O2
Molecular Weight
480.500000
Exact Mass
480.202222
InChI
InChI=1S/C26H24N8O2/c1-16-10-17(5-7-22(16)36-19-8-9-34-23(12-19)28-15-30-34)31-24-20-11-18(4-6-21(20)27-14-29-24)32-25-33-26(2,3)13-35-25/h4-12,14-15H,13H2,1-3H3,(H,32,33)(H,27,29,31)
InChIKey
SDEAXTCZPQIFQM-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
36
Aromatic heavy atom count
25
Fraction Csp3
0.19
Rotatable bonds
5
H-bond acceptors
10
H-bond donors
2
Molar refractivity
138.15
TPSA
110.85
LogP / Solubility
WLOGP
5.09
MLOGP
4.52
XLogP3
4
Consensus LogP
4.54
Log S (ESOL)
-6.21
Class (ESOL)
Insoluble
Log S (Ali)
-7.18
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.61
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.03
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
5.5